Perfuse Therapeutics Announces FDA Clearance of IND Applicat

Perfuse Therapeutics Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of PER-001 Intravitreal Implant in Patients with Glaucoma

Perfuse Therapeutics Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of PER-001 Intravitreal Implant in Patients with Glaucoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

North Carolina , United States , California , San Francisco , Sevgi Gurkan , Phil Lai , Linkedin , Perfuse Therapeutics Inc , Drug Administration , Perfuse Therapeutics , Investigational New Drug , Chief Medical Officer ,